Cytosorbents Corp
CTSO
CTSO
78 hedge funds and large institutions have $33.9M invested in Cytosorbents Corp in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
42% less capital invested
Capital invested by funds: $58.8M → $33.9M (-$24.9M)
Holders
78
Holding in Top 10
–
Calls
$63K
Puts
$44K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$548K | |
| 3 | +$444K | |
| 4 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$432K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$368K |
Top Sellers
| 1 | -$4.06M | |
| 2 | -$1.24M | |
| 3 | -$734K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$638K |
| 5 |
Goldman Sachs
New York
|
-$532K |